US Stock MarketDetailed Quotes

DRMA Dermata Therapeutics

Watchlist

1.2600
-0.1000-7.35%

Close Jan 8 16:00 ET

1.2900
+0.0300+2.38%

Post 20:01 ET

2.57MMarket Cap-0.09P/E (TTM)

Dermata Therapeutics Stock Forum

Clintzilla

Jan 6 09:17

$Dermata Therapeutics (DRMA.US)$ watch this if gets over 1.50

273794940202

Dec 31, 2024 05:21

$Dermata Therapeutics (DRMA.US)$ its about time

This_Guy

Dec 25, 2024 18:10

$Dermata Therapeutics (DRMA.US)$
On watch

70899736

Dec 16, 2024 15:24

$Dermata Therapeutics (DRMA.US)$ fda approvsl news but stock not moved. anything missing here

273794940202

Dec 16, 2024 08:38

$Dermata Therapeutics (DRMA.US)$ lolllll

Clintzilla

Dec 16, 2024 08:18

$Dermata Therapeutics (DRMA.US)$ - YouTube

273794940202

Dec 16, 2024 08:09

$Dermata Therapeutics (DRMA.US)$ weakkk

Trytosaveabit

Dec 16, 2024 08:08

News

$Dermata Therapeutics (DRMA.US)$ Dermata Receives Approval From FDA For The Proprietary Name Xyngari For Its Phase 3 Acne Candidate
Benzinga· 3 mins ago

Jaguar8

Dec 16, 2024 08:02

NEWS

$Dermata Therapeutics (DRMA.US)$
Dermata Receives Approval from FDA for the Proprietary Name Xyngari(TM)
Monday, 16th December at 9:00 am
- Xyngari (formerly DMT310) is currently being studied in Phase 3 for the treatment of acne, with topline results from the first Phase 3 STAR-1 study expected in March 2025 -
SAN DIEGO, CA / ACCESSWIRE / December 16, 2024 / Dermata Therapeutics, Inc. (NASDAQ: DRMA)(NASDAQ: DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on t...